Literature DB >> 20005487

The pathogenesis of HIV-associated nephropathy.

Lewis Kaufman1, Susan E Collins, Paul E Klotman.   

Abstract

HIV-associated nephropathy (HIVAN) is one of the leading causes of ESRD in HIV-1-seropositive patients. Patients typically present with heavy proteinuria and chronic renal failure with pathologic findings of collapsing focal segmental glomerulosclerosis (FSGS). The disease is caused by direct infection of renal epithelial cells by HIV-1 in a genetically susceptible host. The genetic factors responsible for the susceptibility to HIVAN among blacks include a noncoding variant in the podocyte-expressed gene nonmuscle myosin, heavy chain 9 (MYH9) as well as other genes yet to be identified. Podocyte and tubular dysfunction results from the expression of viral genes, in particular nef and vpr, and the subsequent dysregulation of numerous host factors, including critical signaling pathways, inflammatory mediators, and others. The identification of these factors has the potential to provide novel therapeutic targets to prevent and treat this important disease.

Entities:  

Mesh:

Year:  2010        PMID: 20005487     DOI: 10.1053/j.ackd.2009.08.012

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  8 in total

1.  Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient.

Authors:  Kerstin Amann; Christian Bogdan; Thomas Harrer; Juergen Rech
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  Glomerular MYH9 expression is reduced by HIV-1.

Authors:  Thomas Hays; Vivette D D'Agati; Jonathan A Garellek; Tjani Warren; Marc E Trubin; Deborah P Hyink; John Cijiang He; Paul E Klotman
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

3.  AT1R blockade in adverse milieus: role of SMRT and corepressor complexes.

Authors:  Tejinder Singh; Kamesh Ayasolla; Partab Rai; Nirupama Chandel; Shabirul Haque; Rivka Lederman; Mohammad Husain; Vasupradha Vethantham; Amrita Chawla; Himanshu Vashistha; Moin A Saleem; Guohua Ding; Praveen N Chander; Ashwani Malhotra; Leonard G Meggs; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-17

4.  Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.

Authors:  C William Wester; John R Koethe; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Aaron M Kipp; Hwanhee Hong; Hermann Bussmann; Tendani Gaolathe; Catherine C McGowan; Timothy R Sterling; Richard G Marlink
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

5.  Living kidney donation in individuals with hepatitis C and HIV infection: rationale and emerging evidence.

Authors:  Luckmini Liyanage; Abimereki D Muzaale; Macey L Henderson; Christine M Durand
Journal:  Curr Transplant Rep       Date:  2019-04-30

Review 6.  Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challenge.

Authors:  Neelja Kumar; Mark A Perazella
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.495

7.  Steroid-responsive nephrotic syndrome and bilateral renal artery stenosis: a possible role for Angiotensin-mediated podocyte injury.

Authors:  Rahul Bhardwaj; Imran Dosani; Barbara A Clark
Journal:  Case Rep Nephrol Urol       Date:  2012-06-05

8.  HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.

Authors:  Manuela Nebuloni; Lidia Zawada; Angelita Ferri; Antonella Tosoni; Pietro Zerbi; Massimo Resnati; Guido Poli; Luca Genovese; Massimo Alfano
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.